(Institutional Investor) At least one hedge fund firm thinks so….In its second-quarter letter, dated August 17 and obtained by Institutional Investor, Suvretta Capital Management — which is not an activist hedge fund — makes the case for the drug giant winding up in the cross-hairs of the activist set…
Could Merck Become an Activist Target? One Hedge Fund Thinks So
This entry was posted in Syndicated. Bookmark the permalink.
